MODV stock trades at $0.43 on NASDAQ intraday 03 Mar 2026 as ModivCare Inc. prepares to report earnings on 04 Mar 2026. The company’s microcap market value sits at $6,199,406.00 with heavy intraday volume of 18,349,172.00 shares, giving the upcoming report outsized price risk. Investors will weigh a deeply negative EPS of -16.09 and wide gaps between the 50-day average ($2.50) and 200-day average ($4.68) against any revenue or margin beats. This earnings spotlight explains key metrics, trade signals, Meyka AI grade, and a model-based forecast for MODV stock ahead of the report.

Earnings snapshot for MODV stock

ModivCare announces results after the close on 04 Mar 2026, making today’s intraday price action sensitive to guidance and contract updates. The market currently lacks a consensus price target and last reported EPS stands at -16.09, reflecting prior sizable charges and restructuring. With the share price at $0.43, even modest revenue or margin surprises could trigger large percentage moves due to the low absolute price.

Financials and valuation of ModivCare Inc. (MODV)

ModivCare shows revenue per share TTM of 186.98 but a negative net income per share of -31.30, producing a negative PE of -0.03. Price-to-sales is 0.00, with book value per share at -32.23 and cash per share of 5.43. The current ratio is 1.64, which indicates short-term liquidity, but free cash flow per share is -13.93, underlining ongoing cash burn and valuation stress relative to peers in Healthcare.

Trading activity and technicals for MODV stock

Shares trade at $0.4319 with volume 18,349,172.00, above the 3-month average volume of 8,269,285.00 and a relative volume of 2.22, showing elevated interest. Short-term indicators are neutral: RSI 48.23, MACD 0.03 (signal 0.03), and ADX 100.00, which the data flags as a strong trend reading. The 50-day average is $2.50 and the 200-day average is $4.68, underscoring the steep historical decline from the 52-week high of $32.82 to the 52-week low of $0.28.

Meyka AI grade and MODV stock forecast

Meyka AI rates MODV with a score out of 100: 69.25 (Grade B) with a suggestion to HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a 12-month base target of $0.60, implying an upside of 38.92% from the current $0.43. Forecasts are model-based projections and are not guarantees.

Risks and catalysts ahead of the MODV stock report

Near-term catalysts include earnings surprises, contract wins in NEMT or Personal Care, and updates on Remote Patient Monitoring. Key risks are continued negative EPS, weak free cash flow, dependency on Medicaid/managed-care reimbursement, and historically wide price swings that can magnify losses. Given the tiny market cap of $6,199,406.00 and heavy recent volume, shareholders should expect episodic liquidity-driven volatility.

Analyst view, rating and sector context for MODV stock

Independent screener data lists a company rating of C+ dated 28 Feb 2025 with a recommendation of Sell on traditional metrics. There is no consensus price target published. Sector dynamics in Healthcare and Medical – Care Facilities remain mixed as payor reforms and Medicaid flows drive contract economics. For traders, the combination of deep valuation anomalies and operational risk makes MODV a high-beta earnings play tracked by quantitative platforms including Meyka AI.

Final Thoughts

The immediate driver for MODV stock is the 04 Mar 2026 earnings release; at $0.4319 today, the market already prices in severe downside and binary upside. Key facts: negative EPS -16.09, market cap $6,199,406.00, and elevated intraday volume 18,349,172.00. Meyka AI’s grade (score 69.25, Grade B, HOLD) balances potential contract-driven recovery against poor free cash flow and a negative book value. Our model projects a 12-month base target of $0.60, implying +38.92% upside versus current price; alternative downside scenarios are well over -30.00% if cash flow weakens or reimbursement headwinds continue. Traders should size positions for volatility and treat the report as an event trade; longer-term investors need clear evidence of durable margin improvement and cash flow stabilization before upgrading conviction. For live disclosure and filings visit ModivCare’s investor site and the Nasdaq quote page for MODV. Meyka AI provides this AI-powered market analysis as a data-driven input, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.